
Publication|Articles|September 1, 2008
September 2008 Oncology News International
Advertisement
Cover Story
The surgeon who challenged the breast ca paradigm
Payer's budget to get right targeted drug to right patient
New paradigm in pancreatic cancer promotes coordinated patient care
DEPARTMENTS
Focus on Breast Cancer
In elderly with early breast ca, stick with standard chemo
Herceptin erases survival difference between HER2- patients
Focus on Colon Cancer
Adding oxaliplatin to FULV trends toward better survival in stage II/III colon cancer
News & Analysis
Reimbursement for new RT lags behind implementation
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Zanidatamab-Based Regimens for First-Line HER2+ Gastric Cancers
2
FDA Grants Priority Review to Dostarlimab in dMMR/MSI-H Rectal Cancer
3
Lenvatinib Combo Holds Ground Against HER2 ADCs in Endometrial Cancer
4
FDA Grants Fast Track Designation to ERAS-0015 for Pancreatic Adenocarcinoma
5






























































